Its expression is higher in luminal type A breast cancer than other aggressive breast cancer subtypes [44] and studies have demonstrated that progesterone receptor-positive (PR+) breast cancers are associated with better prognosis [45–47]. This evidence concerns the gene PGR and breast carcinoma.